CLINICAL_TRIALS
research
· 2017-03-08
Clinical Trial Update: Characterization of Circulating Tumor Cells (CTC) From Patients With Metastatic Breast Cancer Using the CTC-Endocrine Therapy Index
Summary
This study evaluates circulating tumor cells in metastatic breast cancer patients using the CTC-Endocrine Therapy Index, sponsored by Janssen Diagnostics; the s…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Janssen Diagnostics, LLC | Conditions: Metastatic Breast Cancer | Status: COMPLETED